Restricted accessResearch articleFirst published online 2017-08
The Relationship Between Single-Nucleotide Polymorphisms,the Expression of DNA Damage Response Genes,and Hepatocellular Carcinoma in a Polish Population
The molecular mechanism of hepatocellular carcinoma (HCC) is related to DNA damage caused by oxidative stress products induced by hepatitis B virus (HBV) or C (HCV) infection and exposure to environmental pollutants. Single-nucleotide polymorphisms (SNPs) of DNA damage response (DDR) genes may influence individual susceptibility to environmental risk factors and affect DNA repair efficacy, which, in turn, can influence the risk of HCC. The study evaluates a panel of 15 SNPs in 11 DDR genes (XRCC1, XRCC3, XPD, MUTYH, LIG1, LIG3, hOGG1, PARP1, NFIL1, FEN1, and APEX1) in 65 HCC patients, 50 HBV- and 50 HCV-infected non-cancerous patients, and 50 healthy controls. It also estimates the mRNA expression of nine DDR genes in cancerous and adjacent healthy liver tissues. Two of the investigated polymorphisms (rs1052133 and rs13181) were associated with HCC risk. For all investigated genes, the level of mRNA was significantly lower in HCC cancer tissue than in non-cancerous liver tissue. Seven of the investigated polymorphisms were statistically related to gene expression in cancer tissues. The disruption of DDR genes may be responsible for hepatocellular transformation in HCV-infected patients.
Get full access to this article
View all access options for this article.
References
1.
AbbottsR., and WilsonD.M.3rd. (2016). Coordination of DNA single strand break repair. Free Radic Biol Med [Epub ahead of print]; DOI: 10.1016/j.freeradbiomed.2016.11.039
2.
AkbariM., KeijzersG., MaynardS., Scheibye-KnudsenM., DeslerC., HicksonI.D., et al. (2014). Overexpression of DNA ligase III in mitochondria protects cells against oxidative stress and improves mitochondrial DNA base excision repair. DNA Repair (Amst), 16, 44–53.
3.
AlanaziM., PathanA.A., ShaikJ.P., AmriA.A., and ParineN.R. (2013). The C allele of a synonymous SNP (rs1805414, Ala284Ala) in PARP1 is a risk factor for susceptibility to breast cancer in Saudi patients. Asian Pac J Cancer Prev, 14, 3051–3056.
4.
AlotaibiM., SharmaK., SalehT., PovirkL.F., HendricksonE.A., and GewirtzD.A. (2016). Radiosensitization by PARP inhibition in DNA repair proficient and deficient tumor cells: proliferative recovery in senescent cells. Radiat Res, 185, 229–245.
5.
AsagoshiK., TanoK., ChastainP.D.2nd, AdachiN., SonodaE., KikuchiK., et al. (2010). FEN1 functions in long patch base excision repair under conditions of oxidative stress in vertebrate cells. Mol Cancer Res, 8, 204–215.
6.
BaloghJ., VictorD.3rd, AshamE.H., BurroughsS.G., BoktourM., SahariaA., et al. (2016). Hepatocellular carcinoma: a review. J Hepatocell Carcinoma, 3, 41–53.
7.
BoiteuxS., and RadicellaJ.P. (2000). The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys, 377, 1–8.
8.
CaldecottK.W., AoufouchiS., JohnsonP., and ShallS. (1996). XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular ‘nick-sensor’ in vitro. Nucleic Acids Res, 24, 4387–4394.
9.
CaldecottK.W., McKeownC.K., TuckerJ.D., LjungquistS., and ThompsonL.H. (1994). An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol Cell Biol, 14, 68–76.
10.
CampalansA., MoritzE., KortulewskiT., BiardD., EpeB., and RadicellaJ.P. (2015). Interaction with OGG1 is required for efficient recruitment of XRCC1 to base excision repair and maintenance of genetic stability after exposure to oxidative stress. Mol Cell Biol, 35, 1648–1658.
11.
CappelliE., TaylorR., CevascoM., AbbondandoloA., CaldecottK., and FrosinaG. (1997). Involvement of XRCC1 and DNA ligase III gene products in DNA base excision repair. J Biol Chem, 272, 23970–23975.
12.
CardinR., PiciocchiM., BortolamiM., KotsaftiA., BarzonL., LavezzoE., et al. (2014). Oxidative damage in the progression of chronic liver disease to hepatocellular carcinoma: an intricate pathway. World J Gastroenterol, 20, 3078–3086.
13.
ChenH., PuX.Y., ZhangR.P., and A, Z.C. (2014). Association of common SNP rs1136410 in PARP1 gene with the susceptibility to male infertility with oligospermia. J Assist Reprod Genet, 31, 1391–1395.
14.
ChenY., ZhuM., ZhangZ., JiangG., FuX., FanM., et al. (2013a). A NEIL1 single nucleotide polymorphism (rs4462560) predicts the risk of radiation-induced toxicities in esophageal cancer patients treated with definitive radiotherapy. Cancer, 119, 4205–4211.
15.
ChenY.D., ZhangX., QiuX.G., LiJ., YuanQ., JiangT., et al. (2013b). Functional FEN1 genetic variants and haplotypes are associated with glioma risk. J Neurooncol, 111, 145–151.
16.
ChengC.L., JohnsonS.P., KeirS.T., QuinnJ.A., Ali-OsmanF., SzaboC., et al. (2005). Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft. Mol Cancer Ther, 4, 1364–1368.
17.
CoinF., MarinoniJ.C., RodolfoC., FribourgS., PedriniA.M., EglyJ.M. (1998). Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat Genet, 20, 184–188.
18.
CunY., DaiN., XiongC., LiM., SuiJ., QianC., et al. (2013). Silencing of APE1 enhances sensitivity of human hepatocellular carcinoma cells to radiotherapy in vitro and in a xenograft model. PLoS One, 8, e55313.
19.
CzarnyP., KwiatkowskiD., GaleckiP., TalarowskaM., OrzechowskaA., BobinskaK., et al. (2015). Association between single nucleotide polymorphisms of MUTYH, hOGG1 and NEIL1 genes, and depression. J Affect Disord, 184, 90–96.
20.
DasS.K., RehmanI., GhoshA., SenguptaS., MajumdarP., JanaB., et al. (2016). Poly(ADP-ribose) polymers regulate DNA topoisomerase I (Top1) nuclear dynamics and camptothecin sensitivity in living cells. Nucleic Acids Res, 44, 8363–8375.
21.
Di MasoV., AvelliniC., CroceL.S., RossoN., QuadrifoglioF., CesarattoL., et al. (2007). Subcellular localization of APE1/Ref-1 in human hepatocellular carcinoma: possible prognostic significance. Mol Med, 13, 89–96.
22.
DianovaI.I., SleethK.M., AllinsonS.L., ParsonsJ.L., BreslinC., CaldecottK.W., et al. (2004). XRCC1-DNA polymerase beta interaction is required for efficient base excision repair. Nucleic Acids Res, 32, 2550–2555.
23.
DuanC., ZhangW., LuJ., WuH., LiuM., and ZhuW. (2013). DNA repair gene XRCC3 Thr241Met polymorphism and hepatocellular carcinoma risk. Tumour Biol, 34, 2827–2834.
24.
FarinatiF., CardinR., BortolamiM., BurraP., RussoF.P., RuggeM., et al. (2007). Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. J Viral Hepat, 14, 821–829.
25.
FarinatiF., CardinR., DeganP., De MariaN., FloydR.A., Van ThielD.H., et al. (1999). Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection. Free Radic Biol Med, 27, 1284–1291.
26.
FouquerelE., and SobolR.W. (2014). ARTD1 (PARP1) activation and NAD(+) in DNA repair and cell death. DNA Repair (Amst), 23, 27–32.
27.
FuN., YaoH., NanY., and QiaoL. (2016). Role of oxidative stress in hepatitis C virus induced hepatocellular carcinoma. Curr Cancer Drug Targets, 16, DOI: 10.2174/1568009616666160926124043.
28.
GaoR., PriceD.K., SissungT., ReedE., and FiggW.D. (2008). Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1. Mol Cancer Ther, 7, 1246–1250.
29.
GaoX.R., ZhangS.L., YangY.F., and HanG.R. (2014). FEN1-69G>A and 4150G>T polymorphisms and cancer risk in Chinese population. Sci Rep, 4, 6183.
30.
GhoshR., RoyS., KamyabJ., DantzerF., and FrancoS. (2016). Common and unique genetic interactions of the poly(ADP-ribose) polymerases PARP1 and PARP2 with DNA double-strand break repair pathways. DNA Repair (Amst), 45, 56–62.
31.
GollaR.M., LiM., ShenY., JiM., YanY., FuK., et al. (2012). Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks. Hematol Oncol, 30, 175–179.
32.
JiaL., ShafirovichV., GeacintovN.E., and BroydeS. (2007). Lesion specificity in the base excision repair enzyme hNeil1: modeling and dynamics studies. Biochemistry, 46, 5305–5314.
33.
JungstC., ChengB., GehrkeR., SchmitzV., NischalkeH.D., RamakersJ., et al. (2004). Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma. Hepatology, 39, 1663–1672.
34.
KangH., DaiZ., MaX., MaL., JinY., LiuX., et al. (2013). A genetic variant in the promoter of APE1 gene (−656 T>G) is associated with breast cancer risk and progression in a Chinese population. Gene, 531, 97–100.
35.
KasaharaM., OsawaK., YoshidaK., MiyaishiA., OsawaY., InoueN., et al. (2008). Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population. J Exp Clin Cancer Res, 27, 49.
36.
KhodyrevaS.N., and LavrikO.I. (2016). [Poly(ADP-ribose) polymerase 1 as a key regulator of DNA repair]. Mol Biol (Mosk), 50, 655–673 (Article in Russian).
37.
KimH.C., SongJ.S., LeeJ.C., LeeD.H., KimS.W., LeeJ.S., et al. (2014). Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer. Int J Clin Exp Pathol, 7, 6743–6751.
38.
KwiatkowskiD., CzarnyP., GaleckiP., BachurskaA., TalarowskaM., OrzechowskaA., et al. (2015). Variants of base excision repair genes MUTYH, PARP1 and XRCC1 in Alzheimer's disease risk. Neuropsychobiology, 71, 176–186.
39.
LiY., LiS., WuZ., HuF., ZhuL., ZhaoX., et al. (2013). Polymorphisms in genes of APE1, PARP1, and XRCC1: risk and prognosis of colorectal cancer in a northeast Chinese population. Med Oncol, 30, 505.
40.
LinS., WangM., LiuX., LuY., GongZ., GuoY., et al. (2016). FEN1 gene variants confer reduced risk of breast cancer in chinese women: a case–control study. Oncotarget, 7, 78110–78118.
41.
LiuC., and WangH. (2013). XRCC3 T241 M polymorphism is associated risk of hepatocellular carcinoma in the Chinese. Tumour Biol, 34, 2249–2254.
42.
LiuL., ZhouC., ZhouL., PengL., LiD., ZhangX., et al. (2012). Functional FEN1 genetic variants contribute to risk of hepatocellular carcinoma, esophageal cancer, gastric cancer and colorectal cancer. Carcinogenesis, 33, 119–123.
43.
LiuZ.M., LiL.Q., PengM.H., LiuT.W., QinZ., GuoY., et al. (2008). Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma. Cancer Lett, 263, 212–222.
44.
LivakK.J., and SchmittgenT.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods, 25, 402–408.
45.
LoY.L., JouY.S., HsiaoC.F., ChangG.C., TsaiY.H., SuW.C., et al. (2009). A polymorphism in the APE1 gene promoter is associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev, 18, 223–229.
46.
LoRussoP.M., LiJ., BurgerA., HeilbrunL.K., SausvilleE.A., BoernerS.A., et al. (2016). Phase I safety, pharmacokinetic, and pharmacodynamic study of the poly(ADP-ribose) polymerase (PARP) inhibitor veliparib (ABT-888) in combination with irinotecan in patients with advanced solid tumors. Clin Cancer Res, 22, 3227–3237.
47.
LouroH., PinheiroI., CostaP., SousaC., DiasA., BoavidaM.G., et al. (2008). Mutagenic effects of poly (ADP-ribose) polymerase-1 deficiency in transgenic mice. Mutat Res, 640, 82–88.
48.
LuG., DuanJ., ShuS., WangX., GaoL., GuoJ., et al. (2016). Ligase I and ligase III mediate the DNA double-strand break ligation in alternative end-joining. Proc Natl Acad Sci U S A, 113, 1256–1260.
49.
LuJ., ZhangS., ChenD., WangH., WuW., WangX., et al. (2009). Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility. FASEB J, 23, 3459–3469.
50.
LunnR.M., HelzlsouerK.J., ParshadR., UmbachD.M., HarrisE.L., SanfordK.K., et al. (2000). XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis, 21, 551–555.
51.
MaliuchenkoN.V., KulaevaO.I., KotovaE., ChupyrkinaA.A., NikitinD.V., KirpichnikovM.P., et al. (2015). [Molecular mechanisms of regulaion of transcription by PARP1]. Mol Biol (Mosk), 49, 99–113 (Article in Russian).
52.
MassonM., NiedergangC., SchreiberV., MullerS., Menissier-de MurciaJ., and de MurciaG. (1998). XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol, 18, 3563–3571.
53.
MatsudaY., and IchidaT. (2009). Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis. Med Mol Morphol, 42, 138–142.
54.
McNeillD.R., ParamasivamM., BaldwinJ., HuangJ., VyjayantiV.N., SeidmanM.M., et al. (2013). NEIL1 responds and binds to psoralen-induced DNA interstrand crosslinks. J Biol Chem, 288, 12426–12436.
55.
NashR.A., CaldecottK.W., BarnesD.E., and LindahlT. (1997). XRCC1 protein interacts with one of two distinct forms of DNA ligase III. Biochemistry, 36, 5207–5211.
56.
NishimuraM., TakakiA., TamakiN., MaruyamaT., OnishiH., KobayashiS., et al. (2013). Serum oxidative-anti-oxidative stress balance is dysregulated in patients with hepatitis C virus-related hepatocellular carcinoma. Hepatol Res, 43, 1078–1092.
57.
NogueiraA., AssisJ., FaustinoI., PereiraD., CatarinoR., and MedeirosR. (2016). Base excision repair pathway: PARP1 genotypes as modulators of therapy response in cervical cancer patients. Biomarkers, 22, 70–76.
58.
OdellI.D., BarbourJ.E., MurphyD.L., Della-MariaJ.A., SweasyJ.B., TomkinsonA.E., et al. (2011). Nucleosome disruption by DNA ligase III-XRCC1 promotes efficient base excision repair. Mol Cell Biol, 31, 4623–4632.
59.
OhtsuboT., NishiokaK., ImaisoY., IwaiS., ShimokawaH., OdaH., et al. (2000). Identification of human MutY homolog (hMYH) as a repair enzyme for 2-hydroxyadenine in DNA and detection of multiple forms of hMYH located in nuclei and mitochondria. Nucleic Acids Res, 28, 1355–1364.
60.
OsawaK., MiyaishiA., UchinoK., OsawaY., InoueN., NakaraiC., et al. (2010). APEX1 Asp148Glu gene polymorphism is a risk factor for lung cancer in relation to smoking in Japanese. Asian Pac J Cancer Prev, 11, 1181–1186.
61.
PabalanN., Francisco-PabalanO., JarjanaziH., LiH., SungL., and OzcelikH. (2012). Racial and tissue-specific cancer risk associated with PARP1 (ADPRT) Val762Ala polymorphism: a meta-analysis. Mol Biol Rep, 39, 11061–11072.
62.
PatelA.G., FlattenK.S., SchneiderP.A., DaiN.T., McDonaldJ.S., PoirierG.G., et al. (2012). Enhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes. J Biol Chem, 287, 4198–4210.
63.
PetermannE., KeilC., and OeiS.L. (2006). Roles of DNA ligase III and XRCC1 in regulating the switch between short patch and long patch BER. DNA Repair (Amst), 5, 544–555.
64.
RezaeiM., HashemiM., SanaeiS., MashhadiM.A., HashemiS.M., BahariG., et al. (2016). FEN1-69G>A and +4150G>T polymorphisms and breast cancer risk. Biomed Rep, 5, 455–460.
65.
SantonocitoC., ScapaticciM., NedovicB., AnnicchiaricoE.B., GuarinoD., LeonciniE., et al. (2017). XRCC1 Arg399Gln gene polymorphism and hepatocellular carcinoma risk in the Italian population. Int J Biol Markers, 32, e190–e194.
66.
SasakiY. (2006). Does oxidative stress participate in the development of hepatocellular carcinoma?. J Gastroenterol, 41, 1135–1148.
67.
SchmittgenT.D., and LivakK.J. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc, 3, 1101–1108.
68.
ShawkiS.M., MeshaalS.S., El DashA.S., ZayedN.A., and HannaM.O. (2014). Increased DNA damage in hepatitis C virus-related hepatocellular carcinoma. DNA Cell Biol, 33, 884–890.
69.
ShenM., BerndtS.I., RothmanN., MumfordJ.L., HeX., YeagerM., et al. (2005). Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China. Anticancer Res, 25, 537–542.
70.
ShiY.H., WangB., XuB.P., JiangD.N., ZhaoD.M., JiM.R., et al. (2016). The association of six non-synonymous variants in three DNA repair genes with hepatocellular carcinoma risk: a meta-analysis. J Cell Mol Med, 20, 2056–2063.
71.
SimsekD., FurdaA., GaoY., ArtusJ., BrunetE., HadjantonakisA.K., et al. (2011). Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair. Nature, 471, 245–248.
72.
SunamiY., RingelhanM., KokaiE., LuM., O'ConnorT., LorentzenA., et al. (2016). Canonical NF-kappaB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response. Hepatology, 63, 1592–1607.
73.
SzemrajM., Bielecka-KowalskaA., OszajcaK., KrajewskaM., GosR., JurowskiP., et al. (2015). Serum microRNAs as potential biomarkers of AMD. Med Sci Monit, 21, 2734–2742.
74.
TakakiA., and YamamotoK. (2015). Control of oxidative stress in hepatocellular carcinoma: helpful or harmful?. World J Hepatol, 7, 968–979.
75.
TangL.Y., ChenL.J., QiM.L., SuY., SuF.X., LinY., et al. (2013). Effects of passive smoking on breast cancer risk in pre/post-menopausal women as modified by polymorphisms of PARP1 and ESR1. Gene, 524, 84–89.
76.
TentoriL., PortarenaI., TorinoF., ScerratiM., NavarraP., and GrazianiG. (2002). Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G(2)/M cell accumulation induced by temozolomide in malignant glioma cells. Glia, 40, 44–54.
77.
WangC., ZhangF., WangL., ZhangY., LiX., HuangK., et al. (2013). Poly(ADP-ribose) polymerase 1 promotes oxidative-stress-induced liver cell death via suppressing farnesoid X receptor alpha. Mol Cell Biol, 33, 4492–4503.
78.
WangH., ZhangK., QinH., YangL., ZhangL., and CaoY. (2016). Association between PARP1 single nucleotide polymorphism and brain tumors. Mol Neurobiol, 53, 2083–2089.
79.
WangX.G., WangZ.Q., TongW.M., and ShenY. (2007). PARP1 Val762Ala polymorphism reduces enzymatic activity. Biochem Biophys Res Commun, 354, 122–126.
80.
WangY.D., ZhaiW.L., WangH.Y., and XiaX.Q. (2014). An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk. Asian Pac J Cancer Prev, 15, 4443–4448.
81.
WeiH., and YuX. (2016). Functions of PARylation in DNA damage repair pathways. Genomics Proteomics Bioinform, 14, 131–139.
82.
WinerJ., JungC.K., ShackelI., and WilliamsP.M. (1999). Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem, 270, 41–49.
83.
WojcikK.A., SynowiecE., PolakowskiP., BlasiakJ., SzaflikJ., and SzaflikJ.P. (2015). Variation in DNA base excision repair genes in fuchs endothelial corneal dystrophy. Med Sci Monit, 21, 2809–2827.
84.
XuW., LiuS.A., LiL., ShenZ.Y., and WuY.L. (2015). Association between XRCC1 Arg280His polymorphism and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Genet Mol Res, 14, 7122–7129.
85.
XuX., LiuZ., WangJ., XieH., LiJ., CaoJ., et al. (2016). Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma. Oncotarget, 7, 13730–13741.
86.
YangM., GuoH., WuC., HeY., YuD., ZhouL., et al. (2009). Functional FEN1 polymorphisms are associated with DNA damage levels and lung cancer risk. Hum Mutat, 30, 1320–1328.
87.
YangS.F., ChangC.W., WeiR.J., ShiueY.L., WangS.N., and YehY.T. (2014). Involvement of DNA damage response pathways in hepatocellular carcinoma. Biomed Res Int, 2014, 153867.
88.
YangZ., and ZhaoJ. (2015). Effect of APE1 and XRCC1 gene polymorphism on susceptibility to hepatocellular carcinoma and sensitivity to cisplatin. Int J Clin Exp Med, 8, 9931–9936.
89.
YinM., LiaoZ., LiuZ., WangL.E., GomezD., KomakiR., et al. (2011). Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys, 81, e67–73.
90.
YosunkayaE., KucukyurukB., OnaranI., GurelC.B., UzanM., and Kanigur-SultuybekG. (2010). Glioma risk associates with polymorphisms of DNA repair genes, XRCC1 and PARP1. Br J Neurosurg, 24, 561–565.
91.
ZhangS.H., WangL.A., LiZ., PengY., CunY.P., DaiN., et al. (2014a). APE1 polymorphisms are associated with colorectal cancer susceptibility in Chinese Hans. World J Gastroenterol, 20, 8700–8708.
92.
ZhangX.L., LuY., YangS., PengQ.L., WangJ., XieL., et al. (2014b). An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk. Asian Pac J Cancer Prev, 15, 3273–3278.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
